Jiquan Zhang

Person

Shanghai, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 11,591,404
- Issue date Feb 28, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Phosphoglycerate kinase 1 (PGK) promoters and methods of use for ex...
- Patent number 11,459,390
- Issue date Oct 4, 2022
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cancer using a CD33 chimeric antigen receptor
- Patent number 10,851,166
- Issue date Dec 1, 2020
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 10,703,819
- Issue date Jul 7, 2020
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CLL-1 chimeric antigen receptor
- Patent number 10,568,947
- Issue date Feb 25, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 9,815,901
- Issue date Nov 14, 2017
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD33 chimeric antigen receptor
- Patent number 9,777,061
- Issue date Oct 3, 2017
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230220090
- Publication date Jul 13, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...
- Publication number 20230052970
- Publication date Feb 16, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BINDING MOLECULES AGAINST CD3 AND USES THEREOF
- Publication number 20230037682
- Publication date Feb 9, 2023
- Novartis AG
- Brian Walter GRANDA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC MOLECULES TARGETING CLL-1
- Publication number 20210198368
- Publication date Jul 1, 2021
- Novartis AG
- Michael DALEY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210139595
- Publication date May 13, 2021
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210002377
- Publication date Jan 7, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20200215171
- Publication date Jul 9, 2020
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20180312595
- Publication date Nov 1, 2018
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...
- Publication number 20180118834
- Publication date May 3, 2018
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20180044423
- Publication date Feb 15, 2018
- Novartis AG
- Hilmar Erhard Ebersbach
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160096892
- Publication date Apr 7, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160068601
- Publication date Mar 10, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20160051651
- Publication date Feb 25, 2016
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jiquan Zhang

Person

Patents Grantslast 30 patents

Treatment of cancer using a CD123 chimeric antigen receptor

Phosphoglycerate kinase 1 (PGK) promoters and methods of use for ex...

Treatment of cancer using a CD33 chimeric antigen receptor

Treatment of cancer using a CD123 chimeric antigen receptor

Treatment of cancer using a CLL-1 chimeric antigen receptor

Treatment of cancer using a CD123 chimeric antigen receptor

Treatment of cancer using a CD33 chimeric antigen receptor

Patents Applicationslast 30 patents

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...

BINDING MOLECULES AGAINST CD3 AND USES THEREOF

MULTISPECIFIC MOLECULES TARGETING CLL-1

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR